1. Bacci, G., Ferrari, S., Bertoni, F., Mercuri, M., Forni, C., Sottili, S., Gasbarrini, A., Tienghi, A., Cesari, M. and Campanacci, M. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.;J Chemother,1997
2. Bieling, P., Rehan, N., Winkler, P., Helmke, K., Maas, R., Fuchs, N., Bielack, S., Heise, U., Jurgens, H., Treuner, J., Romanowski, R., Exner, U., Kotz, R. and Winkler, K. Tumor size and prognosis in aggressively treated osteosarcoma.;J Clin Oncol,1996
3. Bramwell, VH., Steward, WP., Nooij, M., Whelan, J., Craft, AW., Grimer, RJ., Taminau, AH., Cannon, SR., Malcolm, AJ., Hogendoorn, PC., Uscinska, B., Kirkpatrick, AL., Machin, D. and Glabbeke, MM. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study.;J Clin Oncol,1999
4. Enneking, WF., Spanier, SS. and Goodman, MA. A system for the surgical staging of musculoskeletal sarcoma.;Clin Orthop Relat Res,1980
5. Ham, SJ., Hoekstra, HJ., Graaf, WT., Kamps, WA., Molenaar, WM. and Schraffordt Koops, H. The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.;J Clin Oncol,1996